Lipid Management Webinar- Priory View Medical Centre Leeds
See Sponsors below
WEBINAR
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: Microsoft Teams
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 12:30-12:35 | Welcome & Introduction | CliniLink |
| 12:35-12:50 | Symposium Daiichi Sankyo UK | Paul Rawlings |
| 12:50-1:50 | Benefits of lowering LDL-C in cardiovascular disease | Professor Ahmet Fuat |
| Strategies for primary and secondary prevention of CVD | ||
| Overview of current NICE guidelines on lipid management | ||
| Implementing local pathways for secondary prevention | ||
| Meeting cholesterol targets for CVD prevention, QOF, and audits | ||
| Use of cardiovascular risk assessment tools in primary care | ||
| Practical tips for improving lipid management in everyday practice | ||
| Addressing patient adherence and lifestyle modification | ||
| Role of newer lipid-lowering therapies | ||
| 1:50-2:30 | Q&A & closing | Professor Ahmet Fuat |
Meet the Speaker
Professor Ahmet Fuat
PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP CardiologyProfessor Ahmet Fuat was a GP in Darlington, County Durham for 40 years, where he was CVD and Research Leads for Darlington Primary Care Network and Darlington GP Federation. He was Oberoi Consulting Medical Director from September 2023 to February 2026, is National Programme Director at Clinilink Ltd and has also worked as an Honorary Consultant Lipidologist/GPSI within the diabetes and endocrinology team at County Durham and Darlington Foundation Trust, running a secondary prevention and genetic lipid clinic. He has been a GPSI Cardiology for over 25 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He went on to be a tutor on the course for many years teaching on HF, HVD, AF and IHD. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 2002 with local colleagues.His PhD by research in heart failure diagnosis and management including work on natriuretic peptides generated several publications that have informed guidelines and led to the award of an Honorary Professorial Chair at Durham University. He has contributed to various NICE and ESC CVD and HF guidelines, and RCGP CKD/AKI toolkit. He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular Journals and a peer reviewer for most high impact Cardiovascular journals and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh, ESC and the PCCS.He has led many quality improvement initiatives over the years in HF, AF, Lipids, hypertension, diabetes and CKD. His work on HF was included in their BHF blueprint for HF. Much of this work was carried out using Oberoi digital audit platforms as has been replicated by colleagues across the UK, benefiting patients and practices positively.
